INTRODUCTION
Tissue expansion was first described for soft tissue in the mid20th century (Neumann 1957 ) and is now an established reconstructive technique in human surgery (Swan 2007 ) . It has a host of potential applications in veterinary surgery (Pavletic 2010 ) , particularly in the field of reconstructing limb cutaneous defects.
Tissue expansion works by inducing "biological creep" (generation of new tissue secondary to a chronic stretching forces) in the skin as opposed to producing tissue elongation beyond inherent extensibility, which is defined as "mechanical creep." Mechanical creep induces a straightening of the convoluted collagen fibres, micro-fragmentation of the elastic fibres and movement of water from the collagen network. Conversely, the new tissue generated by "biological creep" (similar to events such as pregnancy, skin growth over tumours or obesity) undergoes completely different molecular and cellular changes with epidermal thickening and angiogenesis (Wilhelmi et al . 1998 ).
Soft tissue expansion in the limbs of dogs has the advantage of producing additional skin for use in reconstructive procedures where there is otherwise limited local tissue available for the rotation or advancement of a skin flap (Swaim 1980 ) . It is widely regarded that large skin defects of the limb, especially the distal limb, are often difficult to manage (Spodnick et al . 1993 ) ; treatment often requires prolonged open wound care and secondintention healing (Bright RM 1985 , Prpich et al . 2014 ) with or without free skin grafts (Riggs et al . 2015 ) .
Since its inception, tissue expansion has been achieved by inflating a silicone balloon placed subcutaneously, using saline to fill the balloon through a subcutaneous (or occasionally an external) port. The technique was first reported in veterinary medicine in 1989 in three horses, one heifer and one dog (Madison et al . 1989 ). Subsequently, the technique was refined more specifically to expand skin over the distal extremities in dogs (mid crus and mid antebrachium) in both experimental (Keller et al . 1994 ) and clinical settings (Spodnick et al . 1993 , Keller et al . 1994 . It was noted that even if the expanders were well tolerated with few complications, mild discomfort resulted from percutaneous injections to fill the balloon (Keller et al . 1994 ) . Furthermore, the need for weekly expansion through a buried port can be painful and time consuming and may lead to an increased rate of port site infection with potentially greatly increased costs to the owner. The physical bulk of traditional balloon-type expanders also often precluded their use in specific anatomical locations (Swan et al . 2012 ) . These limitations led to the development of self-inflating tissue expanders (STE).
A STE is an osmotic expander formed of a hydrogel core (inert hygroscopic polymer) and external silicone coating. Once implanted, water is drawn by osmosis from the surrounding tissues into the device, which spontaneously expands. The rate and extent of expansion is controlled by the external silicone coating (Chummun et al . 2010 ) . A STE has many advantages over the traditional balloon devices. The absence of a filling port and the ability of the hydrogel to conform to almost any configuration (Swan et al . 2011 ) enable this novel type of tissue expander to be used in a greater range of anatomical locations than balloon devices. The indications for a STE in skin reconstruction in human medicine include: the expansion of a flap to resurface an adjacent defect, the expansion of tissue before placing an implant and the pre-expansion of a flap or graft donor site (Sharpe & Coleman 1992 ) . They have been used for breast reconstruction, cleft palate repair and scar and burn resection (Berge et al . 2001 , Ronert et al . 2004 , Chummun et al . 2010 , Lohana et al . 2012 .
The use of STE has never before been reported in veterinary clinical species. The purpose of this prospective study was, therefore, to report the technique of placement and clinical outcome in dogs with limb defects that were managed using STE across North America, UK and Europe. This case series reports the use of a novel self-inflating anisotropic hydrogel tissue expander, which consists of a hydrogel core coated in medical grade silicone, manufactured according to ISO 13485 standards for prospective human usage.
MATERIALS AND METHODS
The study received ethical approval from the Institutional Ethical Review Committee of the University of Bristol.
Cases managed with the STE (Expaniderm; Oxtex Ltd) (Fig 1 ) were prospectively included and signalment, clinical history, reason for expander use, surgical technique, owner satisfaction, expander ease of use and clinical outcome, including complications, were recorded.
The device expands in three phases: a delay phase of 3-4 days after implantation when no expansion occurs, which also permits initial wound healing; then a controlled phase of linear expansion, followed by a plateau phase (reached within 2-4 weeks) when the device is fully expanded and remains so until it is removed for the second-stage reconstruction.
Dogs were included if they were presented with a skin defect on a limb that could not be closed without a skin graft, flap or tissue expansion. Active infection (evidenced by culture results or visual inspection) was a contraindication. In the case of tumour resection, the preliminary cytology or histopathology results was first confirmed. All therapeutic options were presented to owners; some guidance was offered, but the decision to proceed with skin expansion was based on the owners' decisions and their informed consent. Cases were excluded if follow-up was not available or if the information regarding tumour grading or staging was insufficient.
Cases were divided into three groups based on anatomical positioning of the expanders. Group A (n=4) comprised dogs in which the expanders were placed on, or proximal to, the elbow and stifle. Group B (n=4) comprised dogs in which expanders were placed distal to the elbow and proximal to the carpus and distal to the stifle but proximal to the tarsus. Group C (n=4) comprised cases where expanders were placed distal to the carpus and tarsus.
Indications for placing the expanders were as follows: before malignant tumour resection (n=5), before non-malignant tumour resection (n=3) and to aid primary wound closure of non-healing wounds (n=4). Table 1 documents case descriptions and indications for expansion for all cases included in the study.
Owner satisfaction was evaluated by the veterinary surgeon performing the surgery once the wound had fully healed and was graded as "satisfied" or "not satisfied." Expander ease of use, as assessed by the veterinary surgeon, was graded as "good" (expanders implanted as planned, including location and number of devices), "fair" (expanders not implanted as planned in either location and numbers but leading to satisfactory/complete reconstruction) or "poor" (expanders not implanted as planned, leading to partial reconstruction).
Clinical outcome was defined according to the quality of wound closure and complications. Outcome was categorised into four groups:
• Excellent : no complications during implantation or skin expansion and full reconstruction.
• Good : minor complications during implantation or expansion; full or partial reconstruction needing no further surgery after reconstruction.
• Fair : major complications during implantation or expansion; full or partial reconstruction and no further surgical intervention required after reconstruction.
• Poor : major complications during implantation or expansion requiring further care under sedation or anaesthesia; partial or no reconstruction.
All dogs had two general anaesthetics, one for the initial implantation and a second for the subsequent removal and wound reconstruction. Analgesia was provided with a combination of opioids and non-steroidal anti-inflammatory drugs (NSAID) as appropriate. All dogs were induced, following premedication, using intravenous anaesthetic agents and were maintained on isofluane or sevofluane. Prophylactic antimicrobials (including amoxicillin-clavulanic acid, second-generation cephalosporin or metronidazole) were administered perioperatively to all dogs. Metronidazole was administered in only one dog based on culture and susceptibility testing. Dogs with open wounds were treated with antimicrobials based on culture and sensitivity testing wherever possible (n=2). Postoperative infections were treated with antibiotics based on culture and sensitivity when possible. The use of bandages and wound drains was according to the veterinary surgeon's preference.
Implantation technique
The implantation technique followed a series of specific guidelines: (1) the incision for device insertion was made away from the proposed position of the device to minimise the risk of wound dehiscence during expansion; (2) the incision was made in normal skin, avoiding scar tissue, ulcerated or highly irradiated skin; (3) care was taken so that the incision did not compromise the vascularity of the subsequent skin flap (Swan 2007 ) , and whenever possible, the incision was made such that it preserved the proximal blood supply; (4) in oncological cases, the incision was made beyond the planned margins for tumour removal; (5) blunt dissection was used to create a subcutaneous pocket, and the pocket was made sufficiently large to accommodate the STEs; this was checked using a trial device of the same size as the STE before final implantation; (6) when inserting the STEs, care was taken not to damage the silicone membrane coating the expander ( e.g . avoidance of handling with toothed forceps); (7) dead space was closed to prevent migration of the STEs; and (8) meticulous haemostasis to reduce the risk of haematoma formation. Incisions were closed routinely (Figs 2 and 3). Two expander types were used; both were cylindrical with a diameter of 27 mm, but one had a height of 5 mm and expanded to 18 mm, whereas the other had an initial height of 9 mm and expanded to 25 mm (Fig 1 ) .
Explantation technique
Devices were removed through the incision created at the leading edge of the skin flap whenever possible, but this was dependent on anatomical location. If the expander had created a fibrous capsule, scoring or excision of the capsule allowed the elasticity of the overlying skin flap to be restored. During scoring, care was taken not to compromise the vascularity of the skin flap. Following explantation, the skin defect was reconstructed fully or partially using the expanded skin either to aid direct primary closure or as an advancement flap.
RESULTS
Thirteen consecutive dogs with skin defects on the limb and managed with STE between July 2014 and March 2016 were assessed. All cases were treated by different veterinary surgeons in a number of institutions. One case was excluded from this report due to loss of follow-up. For one further case, we could not report the outcome on reconstruction, expansion and wound closure following STE placement as they had to be removed within 24 hours ( i.e . before any inflation had occurred). Therefore, outcome of implantation technique, rate and type of complications and procedure grading are reported for 12 cases, whereas outcome of expansion, type of reconstruction techniques used and wound closure are only reported for 11 cases.
Implantation and Expansion
A mean of five STEs were implanted per dog (range two to nine). Devices were explanted after a mean of 24 days (range 13 to 42 days). In six cases, the STEs expanded as intended without complication. In two cases, both in Group C, major complications were seen during expansion: in one dog, the STEs extruded through the skin, and in the other case, the devices were removed early because of skin necrosis overlying the devices. In another dog in Group C, the devices were removed 24 hours after implantation. In this case, the unexpanded devices were placed on the palmar aspect of the carpal region and appeared to compromise blood supply to the distal forelimb, as evidenced by a profound change in colour of the skin distal to the STE placement site.
Once the expanders were removed, the skin returned to a completely normal colour. One STE in Group A spontaneously ruptured, although there was no macroscopic damage, and full expansion of the skin was achieved. Rupture was thought to be due to incorrect STE handling at implantation. In three cases, minor complications occurred during expansion: two of these were incisional infections (suspected based on visual inspection) in dogs being treated for open wounds. In one dog from Group C, there was minor tissue necrosis overlying one of the expanders, which did not affect the clinical outcome. Six dogs were bandaged throughout expansion.
Reconstruction
All dogs underwent a second general anaesthetic for reconstruction. STEs were removed, and in cases with a mass to be resected, this was undertaken during the same anaesthetic episode. In six cases, the expanded skin was used as an advancement flap, and in five cases, the expanded skin was used to aid direct primary closure.
Wound closure
This was assessed in 11 of the 12 cases. Primary closure was achieved in eight of 11 (73%) cases. In Group A, all four cases achieved primary closure (100%). In Group B, three of the four (75%) cases achieved primary closure. In Group C, one of the three (33%) cases achieved primary closure. Two of the cases from Group A that had initial primary closure subsequently encountered complications. One case developed complete wound dehiscence due to improper device positioning, leading to excessive tension in the area of the defect where no tissue expander had been placed. In the second dog, there was partial ischaemia of the advancement flap caused by inappropriate location of the implantation incision, which disrupted a significant portion of the blood supply to the advancement flap, resulting in nearly 90% of the skin appearing non-viable.
In three cases (one from Group B and two from Group C), primary closure was not achieved, but in all cases, the resultant defect required to heal by second intention was greatly reduced because of the additional available skin. Two of the three cases in Group C failed to achieve primary closure due to tissue necrosis during expansion. In one case, the STEs were removed before full expansion because of necrosis of the overlying tissue, meaning that there was insufficient skin generated for primary closure, although the skin that was expanded was viable and used to reduce the size of the defect. In the second case in Group C, the STEs extruded before explantation, but extra skin was still generated and used to aid primary closure of the original defect, leaving only a small open wound at the donor site that healed, without complication, through second intention. In the one case from Group B where primary closure was not achieved, this resulted from poor placement of the expanders: rather than being placed laterally and medially around the wound to be reconstructed, half the devices were placed proximally, which significantly reduced the ability to use the skin that had expanded. Table 2 outlines all complications and procedure scoring outcomes. One of the 12 cases required additional surgery to remove the implants within 24 hours after initial placement because it was perceived that the implants were disrupting the blood supply to the leg. The three incompletely reconstructed defects and the four cases in which dehiscence occurred all healed by second intention without the need for further surgical intervention. Two dogs developed incisional infections, both of which were successfully treated with antibiosis (amoxicillin and clavulanic acid). The infections did not affect the expansion of the STEs, reconstruction or clinical outcome.
Complications
Two dogs, both from Group C, developed major complications during expansion. One had the STEs removed early, and reconstruction was carried out with partially expanded skin. This resulted in a successful partial reconstruction that went on to heal without complication through second intention. In the second case, the device was extruded, but there was still expanded skin that was used to aid reconstruction. The original defect was closed using the expanded skin, and a small secondary donor defect healed uneventfully through second intention.
Procedure grading
Six of 12 cases were scored as either excellent or good, five of 12 as fair and one of 12 as poor. There were no complications at implantation, and all surgeons scored the ease of use of the device as either good (seven of 12) or fair (five of 12). Eight of 12 owners reported that they were satisfied with the procedure, and four of 12 reported that they were not.
DISCUSSION
This study is the first to present a range of indications, outcomes and complications associated with the STE in a limited number Due to the ease of use and its application in limb reconstruction, the majority of cases were dealt with in first-opinion practices and reflected by the fact that 11 different surgeons took part in this trial. There was extensive support given by both a board-certified veterinary surgeon and a human consultant reconstructive plastic surgeon highly experienced in tissue expansion. Therefore, this product was trialled in a realistic setting for its intended use.
Of the three anatomical groups, Group C had the least favourable outcomes and was the only group to have major complications. The reason for complications distal to the carpus and tarsus is not fully understood, but one possibility is that the pressure of the tissue expander device on the overlying skin exceeds the tissue perfusion pressure in this location, thus leading to local tissue ischaemia and skin necrosis. There was no evidence of skin necrosis when the devices were placed proximal to the carpus or tarsus (Groups A and B). Therefore, it would be recommended that current self-inflating expanders only be placed distal to the carpus or tarsus after careful consideration. It is possible that a device that expands more gradually would potentially overcome the problem of tissue necrosis.
Of the eight cases with devices placed proximal to the tarsus and carpus, six had no complications throughout expansion, and two cases had minor complications, thus demonstrating that the use of these devices in this region is safe and effective. The minor complications were incisional infections, which both resolved completely with antibiotic treatment. None of the minor complications during expansion affected outcome.
Precise and correct anatomical placement of the device is crucial to the quality and quantity of the expanded skin required for reconstruction (Hudson & Grob 2005 ) . It is advised that an expander be placed a minimum distance from the defect and that the expander be 2·5 to 3·0 times the size of the defect to be reconstructed in order to succeed in primary closure (Van Rappard et al . 1988 ). This assumption is based on studies performed on human skin, although studies carried out by Bartell and Mustoe found that there was no statistical difference between human and dog skin when tested for elastic and biomechanical properties, and the dog has been identified as the best animal model for tissue expansion (Bartell & Mustoe 1989 ) . It is therefore not known whether the same principles should apply to canine skin expansion. However, the implant was placed incorrectly in two cases where less than excellent outcomes were achieved. In one case, rather than the devices being placed along the lateral and medial edges of the defect to be reconstructed, five of the eight devices were placed proximally and medially. This meant that although the devices expanded as expected, the extra skin created was difficult to utilise distally.
The expanders tested in this study are anisotropic (only expanding in one vertical direction), and therefore, the additional skin gained is through the increase in height of the device. Thus, the most efficient way to place the STEs in order to achieve the maximal amount of expanded skin is in a longitudinal configuration of the STEs along the length of the defect or, where possible, one row either side of the defect.
Complications arising from tissue expansion are relatively common, but the majority are minor (Malata et al . 1995 ) . In two retrospective studies in humans, the overall complication rates in lower limb tissue expansion was 19·4% and 43%, respectively, of which major complications were respectively seen in 15·5% and 17% (Casanova et al . 2001 , Pandya et al . 2002 .
In this study, major complications were only observed when the STEs were implanted distally to the carpus or tarsus. This is similar to reports in human medicine, where complications of implantation of STEs in the extremities are generally higher than those over the trunk and scalp (Hallock 1987 ) . The reason why one case developed a suspected distal limb ischaemia following STE placement is unknown. This dog was the only one in which the STEs were placed on the palmar aspect of the carpal region, so it could be considered that the STE were interrupting the blood supply to the distal leg from the median artery; however, the reason why the dorsal blood supply from the cranial superficial antebrachial artery did not suffice is unknown. Following this complication, we are now recommending that STEs not be placed in the palmar region of the carpus. In cases of tumour resection, reconstruction was carried out before the margins were known. It is therefore possible that this method of reconstruction could be associated with cancer cell seeding, although we did not encounter this complication in our study. This issue might be more prevalent with tumours such as mast cell tumours and high-grade soft tissue sarcomas, which typically require larger resection margins (Ryan et al . 2012 ). The very low proportion of these tumours in our study population (no high-grade STS and only one mast cell tumour) might explain why we did not encounter local recurrence due to cancer cell seeding. We, however, believe that cancer cell seeding is a potentially serious issue to consider whilst using STE and would advise against their use in the management of feline fibrosarcoma for this reason. An alternative would be to resect the tumour at the time of STE placement. This was not advised as we estimated that the management of an open wound in addition to the management of the STE sites could potentially increase the risk of complications, including infection. We also felt that the presence of an open wound could act as a "path of least resistance" and could increase the risk of premature STE dislodgment through the open wound considering that STEs were always placed on the edge of the proposed resection site. Ultimately, the decision to not resect the tumour at the time of STE placement was based on subjective, more than objective, considerations.
Traditional tissue expansion is performed over several weeks to months. It was found that when skin was expanded proximal to the carpus and tarsus, there were no detrimental effects of rapid 2-week expansion, compared with dogs in which the device was expanded more gradually over 4 weeks (Keller et al . 1994 ) . This is supported by Mustoe et al . ( 1987 ) who concluded that rapid tissue expansion (2 weeks in dogs) did not demonstrate any deleterious effects when compared with a more conventional regimen. This was confirmed in the present study. Mean expansion time in this study was 24 days. We started the study aiming for 28 days, but it became apparent that there was little to be gained from leaving the expanders in place for longer than 14 days, which is our current expansion time recommendation.
Even if the small number of included cases precludes drawing definitive conclusions, it does not presently appear that the incidence of complications is correlated with an increase number of STEs placed. In fact, in two of the cases in which the STEs were placed adjacent to open non-healing wounds, both wounds spontaneously started to contract. There may be two reasons for this. Firstly, the dissection of a subcutaneous pocket causes a delay phenomenon, which increases the rate of wound healing due to dilation of existing vessels (Taylor et al . 1992 ) ; secondly, the mechanical stress placed on the skin by the expanding STE may result in an increase in local angiogenesis. In a prospective soft-tissue reconstruction study in humans using traditional balloon expanders, increased expression of vascular endothelial growth factor (VEGF), a major angiogenic cytokine, was demonstrated compared to non-expanded control patients (Lantieri et al . 1998 ) .
In dogs, several options can be used for reconstruction on the distal limb, including allowing a wound to heal via second intention (with or without the adjunct of negative wound pressure therapy), surgical closure by skin grafting, distant direct skin flaps (pouch or hinged flaps), pre-suturing of tissue surrounding the wound and placement of devices that achieve gradual closure of the wound (Velcro pads, etc.). Of all these techniques, second-intention healing and skin grafting are the most common. Second-intention healing has the advantage of requiring less surgical knowledge and may be attractive to an owner due to the lack of a surgical fee. It can be very useful in contaminated or infected wounds. However, secondary intention is often protracted, may provide poor cosmetic results and might result in functional disability due to scar tissue. Owners often underestimate the costs of prolonged dressings. Prpich reported a 25·8% long-term complication in dogs that had second-intention healing after wide local excisions of STS in the distal limb, including intermittent disruption of the epidermis and decreased range of motion of the carpus due to scar contracture (Prpich et al . 2014 ) . Free skin grafts have the advantage of a single operation with quicker healing times, as well as potentially improved cosmetic and functional outcomes. However, they can be technically more challenging with associated donor site morbidity. The success of the graft is mainly reliant on the establishment of a viable blood supply from the wound bed, and thus, graft survival is more challenging, although possible, over exposed bone, joint, tendon or similarly poorly vascularised tissue. Tissue expansion offers an alternative to these; it is a simple technique to perform, utilising adjacent skin with an established blood supply, which can therefore be used to resurface any defect regardless of the underlying vascularity.
From this study, it can be concluded that soft tissue expansion can be used successfully as an alternative treatment for the reconstruction of limb defects in dogs in which direct primary closure would otherwise not be achievable. Further research into the uses of tissue expansion in veterinary species is warranted, both with respect to distal limb defects and in alternative surgical indications, including potentially increasing the viability of random and axial pattern flaps by pre-expansion (Cherry et al . 1983 ) using the angiogenic properties of the "biological creep" induced by STEs. The use of pre-expanded flaps would be attractive for veterinary patients to potentially make them stronger to resist necrosis at their extremities, which is one very common problem with these flaps (Aper & Smeak 2003 ) .
